Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Medicis Pharmaceuti..

Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”) today announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the District of Arizona on behalf of purchasers of Medicis Pharmaceutical Corporation (“Medicis”) (NYSE:MRX) securities during the period between October 30, 2003 and September 23, 2008 (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from October 3, 2008. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Darren Robbins of Coughlin Stoia at 800/449-4900 or 619/231-1058, or via e-mail at djr@csgrr.com. If you are a member of this class, you can view a copy of the complaint as filed... [read full story]